Mc. Daniels et al., Transcriptional regulation of transforming growth factor beta 1 by glucose: Investigation into the role of the hexosamine biosynthesis pathway, AM J MED SC, 319(3), 2000, pp. 138-142
Citations number
33
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background: The hexosamine biosynthesis pathway (HBP) is hypothesized to me
diate many of the adverse effects of hyperglycemia. We have shown previousl
y that increased flux through this pathway leads to induction of the growth
factor transforming growth factor-alpha (TGF-alpha) and to insulin resista
nce in cultured cells and transgenic mice. TGF-beta is regulated by glucose
and is involved in the development of diabetic nephropathy. We therefore h
ypothesized that the HBP was involved in the regulation of TGF-beta by gluc
ose in rat vascular and kidney cells. Methods: A plasmid containing the pro
moter region of TGF-beta 1 cloned upstream of the firefly luciferase gene w
as electroporated into rat aortic smooth muscle, mesangial, and proximal tu
bule cells. Luciferase activity was measured in cellular extracts from cell
s cultured in varying concentrations of glucose and glucosamine. Results: G
lucose treatment of all cultured cells led to a time- and dose-dependent st
imulation in TGF-beta 1 transcriptional activity, with high (20 mM) glucose
causing a 1.4- to 2.0-fold increase. Glucose stimulation did not occur unt
il after 12 hours and disappeared after 72 hours of treatment. Glucosamine
was more potent: than glucose, with 3 mM stimulating up to a 4-fold increas
e in TGF beta 1-transcriptional activity. The stimulatory effect of glucosa
mine was also dose-dependent but was slower to develop and longer lasting t
han that of glucose. Conclusions: The metabolism of glucose through the HBP
mediates extracellular matrix production, possibly via the stimulation of
TGF-beta in kidney cells. Hexosamine metabolism therefore, may play a role
in the development of diabetic nephropathy.